Skip to main content
. 2023 Dec 12;29(12):3050–3058. doi: 10.1038/s41591-023-02600-4

Extended Data Fig. 6.

Extended Data Fig. 6

Cost-effectiveness for different regions (A) East Asia & Pacific; (B) Europe & East Asia; (C) Latin America & Caribbean; (D) Middle East & North Africa; (E) South Asia; (F) Sub-Saharan Africa. *All positive women treated after assessment of eligibility for ablative treatment. **Triage positive referred to colposcopy. ^^VIA triage positive women treated after assessment of eligibility for ablative treatment. ^HPV16/18 positive women treated after assessment of eligibility for ablative treatment; Women positive for HPV types other than HPV 16/18 (‘OHR’) are triaged with VIA.0% discount rate for effect, 3% discount rate for cost. HALY: health-adjusted life-years.